Search research articles
Contact Us
Filters
Showing results (31-40 of 97) with videos related to
Page
of 10
Sort By:
Blood Cancer Journal
|
October 27, 2021
Lifestyle considerations in multiple myeloma
Yael N Shapiro, Jeffrey M Peppercorn, Andrew J Yee, et al.
Skeletal Radiology
|
June 27, 2016
Abdominal adipose tissue in MGUS and multiple myeloma
Joyce Veld, Elizabeth K O'Donnell, Michaela R Reagan, et al.
Transplantation Direct
|
April 12, 2024
Successful Treatment of Posttransplant Monoclonal Gammopathy-associated C3 Glomerulopathy With Plasma Cell Clone-directed Therapy
Ayman Al Jurdi, Abraham Cohen Bucay, Leonardo V Riella, et al.
Blood Cancer Journal
|
April 22, 2026
Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T
Joshua N Gustine, Narsis Attar, Benjamin R Puliafito, et al.
Skeletal Radiology
|
September 16, 2018
Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states
F Joseph Simeone, Joel P Harvey, Andrew J Yee, et al.
Blood
|
July 20, 2023
Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells
Philipp Karschnia, Kevin C Miller, Andrew J Yee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 1, 2023
Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
Hazim S Ababneh, Andrew J Yee, Noopur S Raje, et al.
Ebiomedicine
|
July 3, 2015
Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma
Elizabeth O'Donnell, Anuj Mahindra, Andrew J Yee, et al.
JAMA Oncology
|
August 22, 2018
Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical Trial
Ajay K Nooka, Michael Luhua Wang, Andrew J Yee, et al.
Blood Advances
|
April 9, 2025
Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma
Joshua N Gustine, Andrew R Branagan, Diana D Cirstea, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 97) with videos related to
Sort By:
Page
of 10
Blood Cancer Journal
|
October 27, 2021
Lifestyle considerations in multiple myeloma
Yael N Shapiro, Jeffrey M Peppercorn, Andrew J Yee, et al.
Skeletal Radiology
|
June 27, 2016
Abdominal adipose tissue in MGUS and multiple myeloma
Joyce Veld, Elizabeth K O'Donnell, Michaela R Reagan, et al.
Transplantation Direct
|
April 12, 2024
Successful Treatment of Posttransplant Monoclonal Gammopathy-associated C3 Glomerulopathy With Plasma Cell Clone-directed Therapy
Ayman Al Jurdi, Abraham Cohen Bucay, Leonardo V Riella, et al.
Blood Cancer Journal
|
April 22, 2026
Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T
Joshua N Gustine, Narsis Attar, Benjamin R Puliafito, et al.
Skeletal Radiology
|
September 16, 2018
Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states
F Joseph Simeone, Joel P Harvey, Andrew J Yee, et al.
Blood
|
July 20, 2023
Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells
Philipp Karschnia, Kevin C Miller, Andrew J Yee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 1, 2023
Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
Hazim S Ababneh, Andrew J Yee, Noopur S Raje, et al.
Ebiomedicine
|
July 3, 2015
Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma
Elizabeth O'Donnell, Anuj Mahindra, Andrew J Yee, et al.
JAMA Oncology
|
August 22, 2018
Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical Trial
Ajay K Nooka, Michael Luhua Wang, Andrew J Yee, et al.
Blood Advances
|
April 9, 2025
Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma
Joshua N Gustine, Andrew R Branagan, Diana D Cirstea, et al.
Page
of 10